References
- Nanetti L, Raffaelli F, Giulietti A, et al. Oxytocin, its antagonist Atosiban, and preterm labor: a role for placental nitric oxide. J Matern Neonatal Med. 2015;28:611-616.
- Kamel RM. The onset of human parturition. Arch Gynecol Obstet. 2010;281:975-982.
- Arrowsmith S, Wray S. Oxytocin: Its Mechanism of Action and Receptor Signalling in the Myometrium. J Neuroendocrinol. 2014;26:356-369.
- Åkerlund M. Targeting the oxytocin receptor to relax the myometrium. Expert Opin Ther Targets 2006;10:423-427.
- Manning M, Misicka A, Olma A, et al. Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics. J Neuroendocrinol 2012;24:609-628.
- Duckitt K, Thornton S, O’Donovan OP, Dowswell T. Nitric oxide donors for treating preterm labour. Duckitt K, ed. Cochrane database Syst Rev 2014; 5:CD002860.
- Maciejewski TM, Lecka R, Chelchowska M, Mikulska B, Laskowska-Klit T. Serum nitric oxide metabolites as a predictive factor of premature delivery. Pol Merkur Lekarski 2015;39:14-17.
- Shahshahan Z, Nourbakhsh M, Jazi FE. Maternal plasma nitric oxide metabolites and cervical length assessment in predicting the tocolytic therapy in preterm labor in Isfahan. J Res Med Sci. 2016; 21:128.
- Momohara Y, Sakamoto S, Obayashi S, Aso T, Goto M, Azuma H. Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat. Mol Hum Reprod. 2004;10:505-512.
- Salas SP. Role of nitric oxide in maternal hemodynamics and hormonal changes in pregnant rats. Biol Res 1998;31:243-250.
- Diejomaoh FME, Omu a E, Al-Busiri N, et al. Nitric oxide production is not altered in preeclampsia. Arch Gynecol Obstet. 2004; 269:237-243.
- Kalidindi M, Velauthar L, Khan K, Aquilina J. The role of nitrates in the prevention of preeclampsia: An update. Curr Opin Obstet Gynecol. 2012;24:361-367.
- Modzelewska B, Kleszczewski T, Kostrzewska A. The effect of a selective inhibition of potassium channels on the relaxation induced by nitric oxide in the human pregnant myometrium. Cell Mol Biol Lett. 2003;8:69-75.
- Modzelewska B, Kostrzewska A. The assessment of a selective inhibition of potassium channels and guanylate cyclase in the relaxation induced by exogenous nitric oxide in the human nonpregnant myometrium. In: Current Topics in Biophysics: XII Conference of Polish Biophysical Society. Wrocław, Poland.Vol 35. Wrocław, Poland: Current Topics in Biophysics 2012:318.
- Cheung BWY, Cartier LL, Russlie HQ, Sawchuk RJ. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies. Fundam Clin Pharmacol 2005;19:347-354.
- Buhimschi I, Yallampalli C, Dong YL, Garfield RE. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol. 1995;172:1577-1584.
- Thomas DD, Miranda KM, Espey MG, et al. Guide for the use of nitric oxide (NO) donors as probes of the chemistry of NO and related redox species in biological systems. Methods Enzymol. 2002;359:84-105.
- Talati C, Ramachandran N, Carvalho JCA, Kingdom J, Balki M. The Effect of Extracellular Calcium on Oxytocin-Induced Contractility in Naive and Oxytocin-Pretreated Human Myometrium In Vitro. Anesth Analg. 2016;122:1498-1507.
- Balki M, Erik-Soussi M, Ramachandran N, Kingdom J, Carvalho JCA. The contractile effects of oxytocin, ergonovine, and carboprost and their combinations: An in vitro study on human myometrial strips. In: Anesthesia and Analgesia. Vol 120.; 2015:1074-1084.
- Bartlett SR, Bennett PR, Campa JS, et al. Expression of nitric oxide synthase isoforms in pregnant human myometrium. J Physiol. 1999; 521 Pt 3:705-716.
- Yallampalli C, Izumi H, Byam-Smith M, Garfield RE. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol. 1994; 170:175-185.
- Luijk P van, Delvigne T. Estimation of parameters of dose–volume models and their confidence limits. Phys Med. 2003;48:1863-1884.
- Black SM, Fineman JR. Oxidative and nitrosative stress in pediatric pulmonary hypertension: Roles of endothelin- 1 and nitric oxide. Vascul Pharmacol. 2006;45:308-316.
- Wimalawansa SJ. Nitric oxide: new evidence for novel therapeutic indications. Expert Opin Pharmacother 2008; 9:1935-1954.
- Ulrich C, Quilici DR, Schlauch KA, Buxton ILO. The human uterine smooth muscle S-nitrosoproteome fingerprint in pregnancy, labor, and preterm labor. AJP Cell Physiol. 2013;305:C803-C816.
- Ali AA, Coulter JA, Ogle CH, et al. The contribution of N2O3 to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation. Biosci Rep. 2013;33.
- Ulrich C, Quillici DR, Schegg K, Woolsey R, Nordmeier A, Buxton ILO. Uterine Smooth Muscle S-Nitrosylproteome in Pregnancy. Mol Pharmacol. 2012;81:143-153.
- Tribe RM, Moriarty P, Dalrymple A, Hassoni AA, Poston L. Interleukin-1β Induces Calcium Transients and Enhances Basal and Store Operated Calcium Entry in Human Myometrial Smooth Muscle 1. Biol Reprod. 2003;68:1842-1849.
- Lockwood CJ, Yen CF, Basar M, et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol. 2008; 172:1571-1579.
- Osol G, Barron C, Gokina N, Mandala M. Inhibition of nitric oxide synthases abrogates pregnancy-induced uterine vascular expansive remodeling. J Vasc Res 2009; 46:478-486.